Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread

Several studies suggest GLP-1 drugs may lower cancer risk. But that benefit may be due to the patients themselves: those who are healthier, wealthier and with better access to care.

By: Ziyad Al-Aly, Washington University in St. Louis, The Conversation

Outlets: The Conversation

Published: July 13, 2026

Words: 1,599

Last Updated: 1 week, 1 day ago

Body Text Preview

By Ziyad Al-Aly, Washington University in St. Louis

In the weeks around the 2026 annual meeting of the American Society of Clinical Oncology, my phone kept buzzing with alerts about GLP-1 drugs and cancer. The headlines were everywhere – from NPR and The Washington Post to Substack and heated exchanges on social media – all circling the same claim: Ozempic might lower the risk of cancer.

Behind those headlines is a real wave of …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us